A Tradition of Quality for
Over 50 Years
For over 50 years, Associates of Cape Cod Inc. — ACC — has been a global leader in endotoxin and (1→3)-β-D-glucan detection products and services. ACC pioneered modern LAL testing methodology and was the first U.S. FDA-licensed company to manufacture LAL reagents. We also developed the first and the only FDA-cleared and CE-marked rapid screening test for invasive fungal infection. Today, ACC is recognized as an international leader in endotoxin and glucan detection and a champion for horseshoe crab sustainability.
PyroSmart NextGen®: Recombinant Cascade Reagent
Officially approved for release testing by several regulatory agencies worldwide. Validating a sustainable, animal free alternative to traditional LAL methods.
Agilent – BioTek Epoch 2 Microplate Spectrophotometer
The BioTek Epoch 2 microplate spectrophotometer is easy to use and integrates with ACC’s Pyros® eXpress software, making it the preferred instrument for endotoxin test methods.
Fungitell®: The Gold Standard in Rapid Screening for IFI
Fungitell® remains the only FDA-cleared and CE-marked rapid test for invasive fungal infection (IFI) that detects (1→3)-β-D-glucan in serum.
World-Class Products and Services to Help You Protect the Health of Patients
ACC pioneered qualitative, quantitative, and recombinant LAL test methods for bacterial endotoxin testing
ACC is the recognized expert in endotoxin test methods and a leading provider of LAL testing reagents and equipment. Pyrotell® lysate was the first U.S. FDA-licensed gel-clot assay for qualitative BET analysis, but we expanded our portfolio to include chromogenic and turbidimetric methods for quantitative results. In 2021, we introduced PyroSmart NextGen®, our recombinant, animal-free technology.
Our experienced laboratory offers custom BET testing services, tailored to meet your needs
ACC’s Contract Test Services (CTS) is a GMP-compliant and ISO-registered laboratory specializing in endotoxin test methods (gel-clot, chromogenic, turbidimetric) and glucan contamination. Endotoxin testing can be performed in accordance with the FDA, United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or Japanese Pharmacopoeia (JP), depending on client specifications.
A reliable test for hospital and reference labs to detect (1→3)-β-D-glucan accurately and rapidly
Invasive fungal infections (IFI) are life‐threatening opportunistic infections that occur in immunocompromised or critically ill people. Fungitell® and Fungitell STAT® provide in-house and external diagnostics labs with a rapid, reliable platform to detect fungal infections earlier, allowing physicians to deliver better care and improve health outcomes for patients.
Serving clinical and reference laboratories, Beacon offers a rapid, cost-effective alternative to in-house IFI testing
Beacon is a fully CLIA-certified reference laboratory specializing in (1→3)-β-D-glucan analysis services to support the diagnosis of invasive fungal infections (IFI). The lab is operated by expert staff who use the Fungitell® product line to test human and veterinary samples. We currently hold certifications and licenses in Massachusetts, California, Maryland, Pennsylvania, and Rhode Island.